ICON, the international contract research organisation (CRO) based in Dublin, Ireland, has lowered its revenue guidance for 2008 but raised its forecast for earnings per diluted share (EPS). ICON, the ...
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments ...
Sees FY25 revenue $8.05B-$8.65B, consensus $8.5B. CEO Steve Cutler commented, “ICON (ICLR) continues to navigate dynamic clinical development market conditions, as trial activity has been impacted by ...
Today, ICON reaffirmed its full year 2024 guidance, with revenue expected to be between $8,260 and $8,300 million, and adjusted EPS in the range of $13.90 to $14.10. In the fourth quarter of 2024, ...
© 2023 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback